Antidepressant use - Concordance between self-report and claims records

被引:82
作者
Kwon, A
Bungay, KM
Pei, Y
Rogers, WH
Wilson, IB
Zhou, Q
Adler, DA
机构
[1] Tufts Univ New England Med Ctr, Hlth Inst, Div Clin Care Res, Boston, MA 02111 USA
[2] Tufts Hlth Plan, Watertown, MA USA
关键词
antidepressant exposure; medication use; self-report; pharmacy claims;
D O I
10.1097/00005650-200303000-00005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND. Researchers need valid methods to assess whether patients are taking their antidepressant medications. Two important sources of data on drug exposure are patients' self-reports and pharmacy claims. OBJECTIVE. To compare self-report and claims data for antidepressant exposure. RESEARCH DESIGN. Cross-sectional analysis. SUBJECTS. This study comprised 422 contemporaneous self-report and claims data points obtained from 164 unique patients in a longitudinal depression study in which patients completed up to five surveys during an 18-month period. MEASURES. For the self-report measure, the following question was asked: Do you now take any prescription medicines for depression? Using claims data, patients were considered to be using an antidepressant if they had filled at least one antidepressant prescription in the 90 days before survey dates. RESULTS. Self-report and claims agreed in 85% (358/422) of cases, with a kappa of 0.69. Eighty-eight percent (56/64) of discrepant cases using other study data sources was resolved. Reasons for discrepancies included the use of medications for conditions other than depression (32/64), recent AD discontinuations (6/64), samples usage (3/64), and low-frequency/PRN use (7/64). CONCLUSIONS. Self-report and claims showed good concordance, but they reflect different truths. Self-report identifies medications intended primarily for the treatment of depressive disorders, whereas claims data identify use of medicines with antidepressant effects. Our assessment of discordant cases showed self-report to be more valid than claims to assess current antidepressant use for depression therapy.
引用
收藏
页码:368 / 374
页数:7
相关论文
共 20 条
[11]   Validation of pharmacy records in drug exposure assessment [J].
Lau, HS ;
deBoer, A ;
Beuning, KS ;
Porsius, A .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (05) :619-625
[12]  
ROGERS WH, 1993, ARCH GEN PSYCHIAT, V50, P517
[13]   Assessing the performance of a new depression screener for primary care (PC-SAD©) [J].
Rogers, WH ;
Wilson, IB ;
Bungay, KM ;
Cynn, DJ ;
Adler, DA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (02) :164-175
[14]   PILL COUNT MEASURES OF COMPLIANCE IN A DRUG TRIAL - VARIABILITY AND SUITABILITY [J].
RUDD, P ;
BYYNY, RL ;
ZACHARY, V ;
LOVERDE, ME ;
MITCHELL, WD ;
TITUS, C ;
MARSHALL, G .
AMERICAN JOURNAL OF HYPERTENSION, 1988, 1 (03) :309-312
[15]   THE NATURAL-HISTORY OF MEDICATION COMPLIANCE IN A DRUG TRIAL - LIMITATIONS OF PILL COUNTS [J].
RUDD, P ;
BYYNY, RL ;
ZACHARY, V ;
LOVERDE, ME ;
TITUS, C ;
MITCHELL, WD ;
MARSHALL, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) :169-176
[16]  
Saunders K, 1998, J CLIN EPIDEMIOL, V51, P883
[17]   Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: the Rotterdam elderly study [J].
Sjahid, SI ;
van der Linden, PD ;
Stricker, BHC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (06) :591-595
[18]  
*STAT, 1999, STAT REF MAN REL 6
[19]   The assessment of refill compliance using pharmacy records: Methods, validity, and applications [J].
Steiner, JF ;
Prochazka, AV .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (01) :105-116
[20]   FUNCTIONAL STATUS AND WELL-BEING OF PATIENTS WITH CHRONIC CONDITIONS - RESULTS FROM THE MEDICAL OUTCOMES STUDY [J].
STEWART, AL ;
GREENFIELD, S ;
HAYS, RD ;
WELLS, K ;
ROGERS, WH ;
BERRY, SD ;
MCGLYNN, EA ;
WARE, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (07) :907-913